We Need to Operate

We Need to Operate

Gallup’s industry sector ratings are based on public perceptions of industry sectors. These are ‘the court of public sentiment’ ratings and encompass criteria including:

1.           Trust: act ethically and responsibly

2.           Experience: deliver quality products /services

3.           Impact:   economic contributions and social responsibility

4.           Reputation: historical performance and public relations

5.           Innovation: future fitness and ability to anticipate and adapt

Spoiler alert, the pharmaceutical industry in the 8/24 release was last.

This . . . the essential industry that changes the course of disease and suffering in living things . . . was seen as the Chicago White Sox of industries. (Sorry White Sox fans - I would have said the NY Giants as I am more of a football fan - but it is just too much this early in the season).


I Cry Foul

When you need them – when you need a medication and it offers relief or even a cure -  it must be the pinnacle of perception for the brand at least. Right?

Perhaps they did not poll many people with illnesses. Perhaps the declining Fans in the Stands are feeling unheard, undersupported, and are simply not getting what they expected.

So maybe, let’s look at it as a canary in a coal mine – a signal that there is trouble a ‘Brewin beneath the surface. Trouble signals often show up in gaps in operational prowess, and that prowess:

  • enhances trust
  • through great experience
  • that has impact on lives
  • which enhances reputations when done with ease and empathy
  • all of which are results and requirements of innovation done beautifully


Diagnose First

Understanding where operations are falling short is an exercise in diagnosis and can be accomplished through solicited and unsolicited customer and customer frontline feedback. lackluster performance erodes trust and the chain to advocacy and adherence weakens further from there on.

Across channels of engagements, the ability to understand where trust is eroded, by unclear, ill-timed, and broken experiences is a matter of asking and observing.

Our operational metrics (O-Data) will tell us what is and mostly what has already happened. But do they tell us why?

 

Experiential data (X-Data) tell us how people felt about an engagement with our brand (digital, field, support, use, access).

Cut Second

Operational Excellence in Pharma customer engagement therefore, can be supported by a more complete diagnosis. It is not unlike the often quoted medical adage that "It is more important to know what kind of a person the disease has, than to know what kind of a disease the person has." they are likely not on your site, seeing your reps, attending your event, or rage-clicking in your prior authorization process because they do not have relevance to the brand at hand.

The Known data are artifacts, symptoms of engagement and operational shortcomings. Enhanced by the Knowable data that is lying in wait guides us to better understanding where we should take actions and what sorts of actions we should take and measure.


Winning in the Court of Public Opinion

We are winding down The Year of Trust and 2025 will build upon that 'price of entry' for showing up in a way that both customers and you and your colleagues connect to one another.


Qualtrics Year of Trust: Trust Creates Value Everywhere

If we deconstruct the Gallup poll or any customer sentiment research and data, the path is pretty clear. The Knowable data is not a nice to have for and industry or relationship for that matter. Uncovering sentiment and acting on gaps and breaks is a great way to run your business and your life.

Felix Evensen

Digital enabler and CX champion with a passion for innovation – Omnichannel Marketing – Digital Customer Experience – Digitalization of Customer Engagement – Digital Operations – Enabling Gen-AI applications

2mo

Thanks for sharing the Gallup-ratings, and your thoughtful perspective, Richard Schwartz, MA. I keep thinking "What an oppportunity pharma had with the pandemic!", and how we blew this chance to become more a part of the public conversation around healthcare, costs and long-term-solutions. Build trust, curate relationships, add value to your customers (HCPs + patients alike). Success is bound to follow.

Croom Lawrence

Fractional CMO | AI Commercial Stack | New Product Launch | Founder & Investor Network | MIT AI & Health

2mo

Brilliant as always

William Flaiz

Transformational Digital Leader | Driving Paid Media, Web Strategy & Innovation | AI & Data-Driven Solutions Expert

2mo

Rich, loved reading your thoughts on trust gaps in pharma. If you had to pick a starting point, where would you tackle first—improving patient experience to enhance trust, or diving into innovation and outreach to boost reputation? Curious to hear where you’d focus initially!

To view or add a comment, sign in

More articles by Richard Schwartz, MA

  • Through Thick and Thin - Pharma's other data opportunity

    Through Thick and Thin - Pharma's other data opportunity

    How did you two meet? We’ve all asked and answered this standard query in our social interactions. “How did you two…

    6 Comments
  • Why a High KQ [Kindness Quotient] Matters Across Pharmaceutical Brand Lifecycles

    Why a High KQ [Kindness Quotient] Matters Across Pharmaceutical Brand Lifecycles

    I first presented the concept of KQ for life sciences brands in 2017 as an approach to move from the trendy customer…

    8 Comments
  • The Digitally Equitable Patient Journey

    The Digitally Equitable Patient Journey

    I was polishing my draft for this month's Digital Health Coalition Newsletter when I took a break to join a live Coffee…

    4 Comments
  • What Do We Do With an Extra Day?

    What Do We Do With an Extra Day?

    Leap days like today, happen (usually every four years) when we add one day to the end of February to align our…

    6 Comments
  • OCTOBER AWE

    OCTOBER AWE

    It has been an Awe-filled thirty days in the evangelization and activation of Customer Experience in Life Sciences. I…

    1 Comment
  • OCTOBER AWE

    OCTOBER AWE

    It has been an Awe-filled thirty days in the evangelization and activation of Customer Experience in Life Sciences. I…

    13 Comments
  • Sam-I-Am: The Inventor of Pharma Omnichannel Customer Experiences

    Sam-I-Am: The Inventor of Pharma Omnichannel Customer Experiences

    Most of us remember the timeless Dr. Seuss book, Green Eggs and Ham.

    8 Comments
  • Broken: Healthcare Customer Experience and a Bridge in Philly

    Broken: Healthcare Customer Experience and a Bridge in Philly

    On June 11th, a major portion of I95 collapsed in Philadelphia due to a fuel truck explosion. Sadly, that driver of the…

    4 Comments
  • Bringing Voice of the Customer into Life Sciences Planning Season

    Bringing Voice of the Customer into Life Sciences Planning Season

    Welcome back from the long Independence Day weekend for all you based in the US. This is a brief guide providing some…

    3 Comments
  • (TaaM) Trust as a Medicine

    (TaaM) Trust as a Medicine

    All the Kings Horses Growing up we learned lessons in Trust from our families and the narratives woven into the…

    3 Comments

Explore topics